These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Role of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes. Welsh JB Diabetes Technol Ther; 2018 Jun; 20(S2):S242-S249. PubMed ID: 29916736 [No Abstract] [Full Text] [Related]
5. Short-term glucose variability in adults with Type 1 diabetes does not differ between insulin pump and multiple daily injection users - a masked continuous glucose monitoring study in clinical practice. Scott ES; McGrath RT; Januszewski AS; Fulcher GR; Jenkins AJ Diabetes Metab; 2020 Apr; 46(2):172-174. PubMed ID: 29937359 [No Abstract] [Full Text] [Related]
7. A Mobile Application Guiding Patients With Type 1 Diabetes Using Sensor-Augmented Insulin Pump Therapy. Esvant A; Lefebvre MA; Campillo-Gimenez B; Lannes M; Delamarre D; Guilhem I; Poirier JY J Diabetes Sci Technol; 2016 Jul; 10(4):985-6. PubMed ID: 26902791 [No Abstract] [Full Text] [Related]
8. An Expert Opinion on Advanced Insulin Pump Use in Youth with Type 1 Diabetes. Bode BW; Kaufman FR; Vint N Diabetes Technol Ther; 2017 Mar; 19(3):145-154. PubMed ID: 28135116 [TBL] [Abstract][Full Text] [Related]
9. Large Treatment Effects With Automated Insulin Delivery System. Slomski A JAMA; 2022 Oct; 328(16):1581-1582. PubMed ID: 36282258 [No Abstract] [Full Text] [Related]
13. Replacement of Blood Glucose Measurements by Measurements With Systems for Real-Time Continuous Glucose Monitoring (rtCGM) or CGM With Intermittent Scanning (iscCGM): A German View. Freckmann G; Schlüter S; Heinemann L; J Diabetes Sci Technol; 2017 Jul; 11(4):653-656. PubMed ID: 28745088 [No Abstract] [Full Text] [Related]
14. [Clinical guidelines in type 1 diabetes mellitus]. Escobar-Jiménez F Endocrinol Nutr; 2009 Dec; 56 Suppl 4():15-7. PubMed ID: 20629224 [No Abstract] [Full Text] [Related]
15. Pre-dinner walks may be superior to post-dinner walks for glucose time in range in adults with type 1 diabetes on hybrid closed-loop insulin delivery systems. Turner LV; Riddell MC Diabetes Obes Metab; 2024 Jun; 26(6):2492-2496. PubMed ID: 38433709 [No Abstract] [Full Text] [Related]
16. Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient. Forlenza GP Diabetes Technol Ther; 2017 Apr; 19(4):206-208. PubMed ID: 28418732 [No Abstract] [Full Text] [Related]
17. Alternative insulin delivery systems: how demanding should the patient be? Polonsky KS; Byrne MM; Sturis J Diabetologia; 1997 Jul; 40 Suppl 2():S97-101. PubMed ID: 9248709 [No Abstract] [Full Text] [Related]
18. How well do patients with type 1 diabetes measure their blood glucose in daily life. Heinemann L; Overmann H; Mühlhauser I Diabetes Care; 1998 Mar; 21(3):461-2. PubMed ID: 9540034 [No Abstract] [Full Text] [Related]
19. Type 1 diabetes technology: advances and challenges. The Lancet Diabetes Endocrinology Lancet Diabetes Endocrinol; 2019 Sep; 7(9):657. PubMed ID: 31439271 [No Abstract] [Full Text] [Related]
20. Insulin Real-Time Advisor-a Decision Support Application for Insulin Therapy Coupled With the Continuous Glucose Monitoring: Impact on Glycemic Control on People With Type 1 Diabetes. Pflaum R; Vaduva P; Allard M; Derrien C; Lefebvre MA; Esvan M; Guilhem I; Guenego A J Diabetes Sci Technol; 2024 Sep; 18(5):1253-1255. PubMed ID: 39044532 [No Abstract] [Full Text] [Related] [Next] [New Search]